SEARCH

SEARCH BY CITATION

References

  • 1
    Report of the national high blood pressure education group on high blood pressure in pregnancy. Am J Obstet Gynecol2000;183:S122.
  • 2
    The world health report: 2005. Make Every Mother and Child Count. Geneva: WHO. [http://www.who.int/whr/2005/whr2005_en.pdf]. Accessed date: 4 June 2011.
  • 3
    Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet2005;365:78599.
  • 4
    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative G. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet2007;369:17918.
  • 5
    Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al.Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol2010;116:40214.
  • 6
    Bujold E, Morency A-M, Roberge S, Lacasse Y, Forest J-C, Giguère Y. Acetylsalicylc acid for the prevention of pre-eclampsia and intra-uterine growth restriction in women with abnormal uterine artery doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can2009;31:81826.
  • 7
    Vainio M, Kujansuu E, Iso-Mustajarvi M, Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG2002;109:1617.
  • 8
    Chiaffarino F, Parazzini F, Paladini D, Acaia B, Ossola W, Marozio L, et al.A small randomized trial of low-dose aspirin in women at high-risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol2004;112:1424.
  • 9
    Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14–16 weeks pregnancy: randomized controlled clinical trial. Croat Med J2005;46:82631.
  • 10
    Harrington K, Goldfrad C, Carpenter RG, Campbell S. Transvaginal uterine artery and umbilical artery Doppler examination of 12–16 weeks and subsequent development of pre-eclampsia and intrauterine growth retardation. Ultrasound Obstet Gynecol1997;9:94100.
  • 11
    Park YW, Cho LS, Choi HM, Kim TY, Lee SH, Yu JK, et al.Clinical significance of early diastolic notch depth: uterine artery Doppler velocimetry in the third trimester. Am J Obstet Gynecol2000;182:12049.
  • 12
    Pihkala J, Hakala T, Voutilainen P, Raivio K. [Characteristic of recent fetal growth curves in finland]. Duodecim1989;105:15406.
  • 13
    Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. [update of Cochrane Database Syst Rev 2004;(1):CD004659; PMID: 14974075] Cochrane Database Syst Rev2007:004659.
  • 14
    Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta2006;27:93958.
  • 15
    Lambers MJ, Groeneveld E, Hoozemans DA, Schats R, Homburg R, Lambalk CB, et al.Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod2009;24:244750.
  • 16
    Haapsamo M, Martikainen H, Tinkanen H, Heinonen S, Nuojua-Huttunen S, Rasanen J. Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study. Hum Reprod2010;25:29727.
  • 17
    Fox C, Khan KS, Coomarasamy A. How to interpret randomised trial of test–treatment combinations: a critical evaluation of research on uterine Doppler test to predict, and aspirin to prevent, pre-eclampsia. BJOG2010;117:8018.
  • 18
    Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol1986;93:104959.
  • 19
    Vainio M, Mäenpää J, Riutta A, Ylitalo P, Ala-Fossi S, Tuimala R. In the dose range of 0.5–2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies. Acta Obstet Gynecol Scand1999;78:828.
  • 20
    Oudejans CB, van Dijk M, Oosterkamp M, Lachmeijer A, Blankenstein MA. Genetics of preeclampsia: paradigm shifts. Hum Genet2007;120:60712.
  • 21
    Roberts JM, Catov JM. Aspirin for pre-eclampsia: compelling data on benefit and risk. Lancet2007;369:17656.
  • 22
    Cuckle HS. Screening for pre-eclampsia--lessons from aneuploidy screening. Placenta2011;32(Suppl.):S428.